Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial
Condition(s):Injection Site IrritationLast Updated:October 6, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Injection Site IrritationLast Updated:October 6, 2022Not yet recruiting
Condition(s):Injection Site IrritationLast Updated:October 20, 2022Completed
Condition(s):Injection Site IrritationLast Updated:December 17, 2020Completed
Condition(s):Injection Site IrritationLast Updated:January 29, 2021Completed
Condition(s):Injection Site IrritationLast Updated:August 17, 2015Completed
Condition(s):Injection Site IrritationLast Updated:October 4, 2019Completed
Condition(s):Injection Site Irritation; Fear of PainLast Updated:December 6, 2022Completed
Condition(s):Anesthesia; Hypothermia; Injection Site IrritationLast Updated:July 15, 2022Recruiting
Condition(s):Injection Site Irritation; PainLast Updated:November 21, 2022Recruiting
Condition(s):Pain Syndrome; Propofol Infusion Syndrome; Injection Site IrritationLast Updated:September 21, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.